These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 27162558)

  • 1. Conformationally Strained trans-Cyclooctene (sTCO) Enables the Rapid Construction of (18)F-PET Probes via Tetrazine Ligation.
    Wang M; Svatunek D; Rohlfing K; Liu Y; Wang H; Giglio B; Yuan H; Wu Z; Li Z; Fox J
    Theranostics; 2016; 6(6):887-95. PubMed ID: 27162558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved metabolic stability for 18F PET probes rapidly constructed via tetrazine trans-cyclooctene ligation.
    Selvaraj R; Giglio B; Liu S; Wang H; Wang M; Yuan H; Chintala SR; Yap LP; Conti PS; Fox JM; Li Z
    Bioconjug Chem; 2015 Mar; 26(3):435-42. PubMed ID: 25679331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrazine-TCO Ligation: A Potential Simple Approach to Improve Tumor Uptake through Enhanced Blood Circulation.
    Wang M; Wang H; Niu CQ; Zhang T; Wu Z; Li Z
    Bioconjug Chem; 2020 Jul; 31(7):1795-1803. PubMed ID: 32491846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
    Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
    Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving Tumor-to-Background Contrast through Hydrophilic Tetrazines: The Construction of
    Feng H; Zhang H; Wang M; Vannam R; Wang H; Yan X; Ouyang W; Jia X; Fox JM; Li Z
    Chemistry; 2020 Apr; 26(21):4690-4694. PubMed ID: 32030822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrazine-trans-cyclooctene ligation for the rapid construction of integrin αvβ₃ targeted PET tracer based on a cyclic RGD peptide.
    Selvaraj R; Liu S; Hassink M; Huang CW; Yap LP; Park R; Fox JM; Li Z; Conti PS
    Bioorg Med Chem Lett; 2011 Sep; 21(17):5011-4. PubMed ID: 21601452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo evaluation of (18)F-labeled TCO for pre-targeted PET imaging in the brain.
    Wyffels L; Thomae D; Waldron AM; Fissers J; Dedeurwaerdere S; Van der Veken P; Joossens J; Stroobants S; Augustyns K; Staelens S
    Nucl Med Biol; 2014 Jul; 41(6):513-23. PubMed ID: 24768149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Organo [
    Otaru S; Imlimthan S; Sarparanta M; Helariutta K; Wähälä K; Airaksinen AJ
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32156020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient 18F labeling of cysteine-containing peptides and proteins using tetrazine-trans-cyclooctene ligation.
    Liu S; Hassink M; Selvaraj R; Yap LP; Park R; Wang H; Chen X; Fox JM; Li Z; Conti PS
    Mol Imaging; 2013; 12(2):121-8. PubMed ID: 23415400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretargeted PET Imaging Using a Bioorthogonal
    Billaud EMF; Belderbos S; Cleeren F; Maes W; Van de Wouwer M; Koole M; Verbruggen A; Himmelreich U; Geukens N; Bormans G
    Bioconjug Chem; 2017 Dec; 28(12):2915-2920. PubMed ID: 29191024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry.
    Meyer JP; Houghton JL; Kozlowski P; Abdel-Atti D; Reiner T; Pillarsetty NV; Scholz WW; Zeglis BM; Lewis JS
    Bioconjug Chem; 2016 Feb; 27(2):298-301. PubMed ID: 26479967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Efficient Method for Labeling Single Domain Antibody Fragments with
    Zhou Z; Devoogdt N; Zalutsky MR; Vaidyanathan G
    Bioconjug Chem; 2018 Dec; 29(12):4090-4103. PubMed ID: 30384599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a (18) F-labeled tetrazine with favorable pharmacokinetics for bioorthogonal PET imaging.
    Denk C; Svatunek D; Filip T; Wanek T; Lumpi D; Fröhlich J; Kuntner C; Mikula H
    Angew Chem Int Ed Engl; 2014 Sep; 53(36):9655-9. PubMed ID: 24989029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labeling a TCO-functionalized single domain antibody fragment with
    Zhou Z; Zalutsky MR; Vaidyanathan G
    Bioorg Med Chem; 2020 Sep; 28(17):115634. PubMed ID: 32773089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Structurally Diverse
    Adhikari K; Dewulf J; Vangestel C; Van der Veken P; Stroobants S; Elvas F; Augustyns K
    ACS Omega; 2023 Oct; 8(41):38252-38262. PubMed ID: 37867688
    [No Abstract]   [Full Text] [Related]  

  • 16. DOTA-tetrazine probes with modified linkers for tumor pretargeting.
    Läppchen T; Rossin R; van Mourik TR; Gruntz G; Hoeben FJM; Versteegen RM; Janssen HM; Lub J; Robillard MS
    Nucl Med Biol; 2017 Dec; 55():19-26. PubMed ID: 29028502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trans-cyclooctene tag with improved properties for tumor pretargeting with the diels-alder reaction.
    Rossin R; van Duijnhoven SM; Läppchen T; van den Bosch SM; Robillard MS
    Mol Pharm; 2014 Sep; 11(9):3090-6. PubMed ID: 25077373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformationally Strained
    Darko A; Wallace S; Dmitrenko O; Machovina MM; Mehl RA; Chin JW; Fox JM
    Chem Sci; 2014 Oct; 5(10):3770-3776. PubMed ID: 26113970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrazine-trans-cyclooctene ligation for the rapid construction of 18F labeled probes.
    Li Z; Cai H; Hassink M; Blackman ML; Brown RC; Conti PS; Fox JM
    Chem Commun (Camb); 2010 Nov; 46(42):8043-5. PubMed ID: 20862423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Evaluation of a Novel
    Ruivo E; Elvas F; Adhikari K; Vangestel C; Van Haesendonck G; Lemière F; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
    ACS Omega; 2020 Mar; 5(9):4449-4456. PubMed ID: 32175492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.